Skip to main content
. 2002 May;160(5):1831–1837. doi: 10.1016/S0002-9440(10)61129-7

Table 1.

ANXA10 mRNA Expression in Benign and Malignant Human Tumors

Tumor type ANXA10 mRNA expression
Expressed Not expressed or dramatically decreased
Hepatocellular carcinoma (n = 182) 61 121 (66%)
Hepatoblastoma (n = 5) 0 5 (100%)
Cholangiocarcinoma (n = 2) 0 2
Metastatic colorectal carcinoma (n = 10)* 0 10 (100%)
Focal nodular hyperplasia (n = 9) 8 1 (11%)
Ovarian carcinoma (n = 16) 0 16 (100%)
Lung carcinoma (n = 3) 0 3
Breast carcinoma (n = 10) 0 10 (100%)

*Includes one ovarian and one breast, and eight metastatic colorectal carcinomas.